The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 23, 2014
Filed:
Feb. 04, 2013
Applicant:
Bristol-myers Squibb Company, Princeton, NJ (US);
Inventors:
Tao Wang, Farmington, CT (US);
Paul Michael Scola, Glastonbury, CT (US);
Zhongxing Zhang, Madison, CT (US);
Zhiwei Yin, Glastonbury, CT (US);
Qian Zhao, Wallingford, CT (US);
Assignee:
Bristol-Myers Squibb Company, Princeton, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 251/52 (2006.01); A61K 31/53 (2006.01); A61P 31/14 (2006.01); C07D 401/14 (2006.01); C07D 513/04 (2006.01); C07D 405/12 (2006.01); C07D 403/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 513/04 (2013.01); C07D 401/14 (2013.01); C07D 405/12 (2013.01); C07D 403/12 (2013.01); C07D 413/12 (2013.01); C07D 251/52 (2013.01); C07D 417/12 (2013.01); C07D 401/12 (2013.01);
Abstract
The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.